Literature DB >> 29147360

A Rare Case of Primary Gastric HIV-Associated Peripheral T-Cell Lymphoma: Relapsed Disease Treated With Pemetrexed.

Jun Gong1, Maria L Delioukina2, Andrew E Hendifar3.   

Abstract

We present a case of a patient with HIV/AIDS who presented with abdominal pain and melena and was found to have gastric peripheral T-cell lymphoma (PTCL). He was treated with 6 cycles of EPOCH with a complete response. Within 3 months, he had central nervous system (CNS) and soft-tissue relapse. He was subsequently treated with 3 cycles of intravenous pemetrexed and experienced a second complete response. To our knowledge, there are fewer than 100 reports of HIV-associated PTCL worldwide as of 2010, and among these cases involvement of the stomach as the primary site of extranodal disease is exceptionally rare. The disease carries a poor prognosis and current standard therapies highlight the importance of HIV/AIDS disease control and the need for more studies on therapies and the role of transplantation in refractory or relapsed HIV-associated PTCL.

Entities:  

Keywords:  HIV/AIDS; Pemetrexed; Peripheral T-cell lymphoma

Year:  2013        PMID: 29147360      PMCID: PMC5649932          DOI: 10.4021/wjon708w

Source DB:  PubMed          Journal:  World J Oncol        ISSN: 1920-4531


  9 in total

1.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Authors:  Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

Review 2.  Peripheral T-cell lymphoma.

Authors:  Francine M Foss; Pier Luigi Zinzani; Julie M Vose; Randy D Gascoyne; Steven T Rosen; Kensei Tobinai
Journal:  Blood       Date:  2011-04-14       Impact factor: 22.113

Review 3.  Peripheral T-cell lymphomas in HIV-infected individuals: a comprehensive review.

Authors:  Jorge Castillo; Kimberly Perez; Cannon Milani; Bruce J Dezube; Liron Pantanowitz
Journal:  J HIV Ther       Date:  2009-06

4.  Risk of T-cell lymphomas in persons with AIDS.

Authors:  R J Biggar; E A Engels; M Frisch; J J Goedert
Journal:  J Acquir Immune Defic Syndr       Date:  2001-04-01       Impact factor: 3.731

5.  Retrospective study of pemetrexed as salvage therapy for central nervous system lymphoma.

Authors:  Jun-Ping Zhang; Eudocia Q Lee; Lakshmi Nayak; Lisa Doherty; Santosh Kesari; Alona Muzikansky; Andrew D Norden; Huichao Chen; Patrick Y Wen; Jan Drappatz
Journal:  J Neurooncol       Date:  2013-07-05       Impact factor: 4.130

6.  Evolving characteristics of AIDS-related lymphoma.

Authors:  A M Levine; L Seneviratne; B M Espina; A R Wohl; A Tulpule; B N Nathwani; P S Gill
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

7.  Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study.

Authors:  Jorge J Castillo; Brady E Beltran; Michele Bibas; Mark Bower; Jaime A Collins; Kate Cwynarski; Jose L Diez-Martin; Francisco Hernandez-Ilizaliturri; Steven M Horwitz; Silvia Montoto; Liron Pantanowitz; Josep-Maria Ribera; Julie M Vose
Journal:  Am J Hematol       Date:  2011-02-15       Impact factor: 10.047

8.  T-cell lymphoma in HIV-infected patients.

Authors:  Karo K Arzoo; Xiangdong Bu; Byron M Espina; Lasika Seneviratne; Bharat Nathwani; Alexandra M Levine
Journal:  J Acquir Immune Defic Syndr       Date:  2004-08-15       Impact factor: 3.731

9.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Authors:  Julie Vose; James Armitage; Dennis Weisenburger
Journal:  J Clin Oncol       Date:  2008-07-14       Impact factor: 44.544

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.